Choi Joon Young, Lee Kyung Soo, Kim Hyung-Jin, Shim Young Mog, Kwon O Jung, Park Keunchil, Baek Chung-Hwan, Chung Jae Hoon, Lee Kyung-Han, Kim Byung-Tae
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Nucl Med. 2006 Apr;47(4):609-15.
In this retrospective study, we investigated whether the (18)F-FDG uptake pattern and CT findings improved the accuracy over the standardized uptake value (SUV) for differentiating benign from malignant focal thyroid lesions incidentally found on (18)F-FDG PET/CT. We also defined the prevalence of these lesions and their risk for cancer.
(18)F-FDG PET/CT was performed on 1,763 subjects without a previous history of thyroid cancer from May 2003 to June 2004. Two nuclear medicine physicians and 1 radiologist interpreted PET/CT images, concentrating on the presence of focal thyroid lesions, the maximum SUV of the thyroid lesion, the pattern of background thyroid (18)F-FDG uptake, and the CT attenuation pattern of the thyroid lesion.
The prevalence of focal thyroid lesions on PET/CT was 4.0% (70/1,763). Diagnostic confirmation was done on 44 subjects by ultrasonography (US)-guided fine-needle aspiration (n = 29) or US with clinical follow-up (n = 15). Among 49 focal thyroid lesions in these 44 subjects, 18 focal thyroid lesions of 17 subjects were histologically proven to be malignant (papillary cancer in 16, metastasis from esophageal cancer in 1, non-Hodgkin's lymphoma in 1). Therefore, the cancer risk of focal thyroid lesions was 36.7% on a lesion-by-lesion basis or 38.6% on a subject-by-subject basis. The maximum SUV of malignant thyroid lesions was significantly higher than that of benign lesions (6.7 +/- 5.5 vs. 10.7 +/- 7.8; P < 0.05). When only the maximum SUV was applied to differentiate benign from malignant focal thyroid lesions for the receiver-operating-characteristic curve analysis, the area under the curve (AUC) of PET was 0.701. All 16 focal thyroid lesions with very low attenuation or nonlocalization on CT images, or with accompanying diffusely increased thyroid (18)F-FDG uptake, were benign. When those lesions were regarded as benign lesions, irrespective of the maximum SUV, the AUC of PET/CT was significantly improved to 0.878 (P < 0.01).
Focal thyroid lesions incidentally found on (18)F-FDG PET/CT have a high risk of thyroid malignancy. Image interpretation that includes (18)F-FDG uptake and the CT attenuation pattern, along with the SUV, significantly improves the accuracy of PET/CT for differentiating benign from malignant focal thyroid lesions.
在这项回顾性研究中,我们调查了¹⁸F-FDG摄取模式和CT表现是否比标准化摄取值(SUV)能提高¹⁸F-FDG PET/CT偶然发现的甲状腺局灶性病变良恶性鉴别的准确性。我们还确定了这些病变的患病率及其癌症风险。
2003年5月至2004年6月,对1763例无甲状腺癌病史的受试者进行¹⁸F-FDG PET/CT检查。两名核医学医师和一名放射科医生解读PET/CT图像,重点关注甲状腺局灶性病变的存在、甲状腺病变的最大SUV、甲状腺¹⁸F-FDG摄取背景模式以及甲状腺病变的CT衰减模式。
PET/CT上甲状腺局灶性病变的患病率为4.0%(70/1763)。44例受试者通过超声(US)引导下细针穿刺(n = 29)或超声结合临床随访(n = 15)进行诊断确认。在这44例受试者的49个甲状腺局灶性病变中,17例受试者的18个甲状腺局灶性病变经组织学证实为恶性(16例为乳头状癌,1例为食管癌转移,1例为非霍奇金淋巴瘤)。因此,甲状腺局灶性病变的逐病变癌症风险为36.7%,逐受试者癌症风险为38.6%。恶性甲状腺病变的最大SUV显著高于良性病变(6.7±5.5 vs. 10.7±7.8;P < 0.05)。在用于鉴别甲状腺局灶性病变良恶性的受试者工作特征曲线分析中,仅应用最大SUV时,PET的曲线下面积(AUC)为0.701。CT图像上所有16个极低衰减或无定位的甲状腺局灶性病变,或伴有甲状腺¹⁸F-FDG摄取弥漫性增加的病变均为良性。当将这些病变视为良性病变,而不考虑最大SUV时,PET/CT的AUC显著提高至0.878(P < 0.01)。
¹⁸F-FDG PET/CT偶然发现的甲状腺局灶性病变具有较高的甲状腺恶性风险。包括¹⁸F-FDG摄取、CT衰减模式以及SUV的图像解读显著提高了PET/CT鉴别甲状腺局灶性病变良恶性的准确性。